Kiniksa (NASDAQ: KNSA) CSO Tessari resigns, signs $450/hour consulting deal
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc reported that Chief Strategy Officer Eben Tessari has decided to resign to pursue another executive role in the life sciences industry. He will leave his officer role on May 15, 2026, but will continue supporting the company as a consultant.
Under a new Consulting Agreement effective May 15, 2026, Tessari will advise on strategic and operational matters and serve as a special advisor to the Science and Research Committee through May 15, 2027, with an option to renew. He will be paid $450 per hour, up to 20 hours per month, plus approved expenses. The company states his resignation is not due to any disagreement regarding its operations, policies, or practices.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Consulting Agreement financial
Emerging growth company regulatory
Item 5.02 regulatory
Science and Research Committee other
FAQ
Why did Kiniksa (KNSA) Chief Strategy Officer Eben Tessari resign?
When is Eben Tessari leaving his officer role at Kiniksa (KNSA)?
What are the main terms of Eben Tessari’s consulting agreement with Kiniksa (KNSA)?
Can Kiniksa (KNSA) or Eben Tessari terminate the consulting arrangement early?
Is Eben Tessari’s consulting agreement with Kiniksa (KNSA) renewable?
What compensation will Kiniksa (KNSA) pay Eben Tessari as a consultant?
AI-generated analysis. How Rhea-AI works. Not financial advice.